[Mechanism of the pharmacological effect of monoamine oxidase inhibitors].
D000447:Aldehydes / Q000037:antagonists & inhibitors; D000818:Animals; D001679:Biogenic Amines / Q000502:physiology; D003641:Deamination; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008928:Mitochondria / Q000187:drug effects / Q000201:enzymology; D008995:Monoamine Oxidase / Q000145:classification / Q000502:physiology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010084:Oxidation-Reduction / Q000187:drug effects; D013379:Substrate Specificity / Q000187:drug effects; D013438:Sulfhydryl Compounds / Q000378:metabolism
D000447:Aldehydes; D001679:Biogenic Amines; D008996:Monoamine Oxidase Inhibitors; D013438:Sulfhydryl Compounds; D008995:Monoamine Oxidase
K voprosu o mekhanizme farmakologicheskogo éffekta ingibitorov monoaminoksidaz.